Lumicef subcutaneous injection 210 mg syringe, manufactured by Kyowa Kirin, contains brodalumab (genetical recombination). This human monoclonal antibody is used to treat moderate to severe plaque psoriasis in adults, especially when other treatments have failed. This product is a 210 mg syringe with YJ code 3999441G1029 and is specified as 20mg 1mL per tube.
Lumicef subcutaneous injection 210 mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).